ストックスクリーナーアプリを入手
0.6751
2.71%
0.0178
アフターアワーズ：
.71
0.0349
+5.17%
前日終値:
$0.6573
開ける：
$0.6599
24時間の取引高:
120.72K
Relative Volume:
0.10
時価総額：
$20.75M
収益：
-
当期純損益:
$-19.54M
株価収益率:
-0.5165
EPS:
-1.3071
ネットキャッシュフロー:
$-21.18M
1週間 パフォーマンス:
-1.80%
1か月 パフォーマンス:
-9.31%
6か月 パフォーマンス:
+3.05%
1年 パフォーマンス:
-74.13%
1日の値動き範囲:
$0.64
$0.6887
1週間の範囲:
$0.6189
$0.6899
52週間の値動き範囲:
$0.4606
$7.20
Calcimedica Inc Stock (CALC) Company Profile
Compare CALC vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
0.6751 | 19.05M | 0 | -19.54M | -21.18M | -1.3071 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Calcimedica Inc Stock (CALC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
Calcimedica Inc (CALC) 最新ニュース
Woodline Partners discloses 8.1% CalciMedica (CALC) stake and sole voting power - Stock Titan
Armistice Capital (CALC) discloses 3.41M-share, 9.99% holding in CalciMedica - Stock Titan
CalciMedica shares see H.C. Wainwright neutral rating reiterated - Investing.com
Price to book forward of CalciMedica, Inc. – BOATS:CALC - TradingView
Price to sales forward of CalciMedica, Inc. – NASDAQ:CALC - TradingView
CalciMedica Inc (CALC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form 8K CalciMedica Inc For: 11 August By Investing.com - Investing.com UK
CalciMedica, Inc. 2Q 2026: Net loss $7.7M, EPS $(0.45) — 10-Q Summary - TradingView
CalciMedica (CALC) cuts expenses, raises $15M but flags going concern risk - Stock Titan
CalciMedica Releases Q2 2026 Financial Results - news.alphastreet.com
CalciMedica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CalciMedica stock gains 6% as pulmonary hypertension progress offsets Q2 earnings miss - Yahoo Finance
CalciMedica Secures Up To $49 Million Private Placement To Advance Pulmonary Hypertension Pipeline - Minichart
CalciMedica Inc reports results for the quarter ended June 30Earnings Summary - TradingView
CalciMedica Q2 FY26 net loss widens to $7.65 million - Bitget
CalciMedica stock gains 6% despite earnings miss on pulmonary trial By Investing.com - Investing.com South Africa
CalciMedica stock gains 6% despite earnings miss on pulmonary trial - Investing.com
CalciMedica reports Q2 2026 results: $18.6M cash, net loss $7.7M; financing to fund PH programs - TradingView
CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates - Moomoo
CalciMedica Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
CalciMedica, Inc. SEC Filing (Aug 3, 2026) - Stock Titan
CalciMedica Inc (CALC:UR): Stock Price, Quote and News - BNN Bloomberg
CalciMedica aligns with FDA on acute pancreatitis trial design By Investing.com - Investing.com Canada
CalciMedica aligns with FDA on acute pancreatitis trial design - Investing.com
CalciMedica Inc (CALC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CalciMedica Inc (CALC) Institutional Confidence - TradingKey
CALC|CalciMedica Inc|Price:0.760|Chg%:+0.044 - TradingKey
CalciMedica Inc (CALC) Cash Flow - TradingKey
CalciMedica Inc (CALC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CalciMedica Inc (CALC) Valuation: PE, PB & Fair Value Analysis - TradingKey
CalciMedica, Inc. Revenue Breakdown – NASDAQ:CALC - TradingView
CalciMedica Inc (CALC) Income Statement - TradingKey
CalciMedica Inc (CALC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CALC|CalciMedica Inc|Price:0.658|Chg%:-0.001 - TradingKey
CALC|CalciMedica Inc|Price:0.721|Chg%:-0.039 - TradingKey
CalcimedicaProspectus Covers Resale Of Up To 56,020,287 Shares Of Common StockSEC Filing - TradingView
CalciMedica (NASDAQ: CALC) files to register 56M shares from June 2026 PIPE - Stock Titan
CalciMedica Inc (CALC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Form DEF 14A ATAI Beckley Inc For: 23 July By Investing.com - Investing.com Canada
CalciMedica, Inc. SEC Filing (Jul 23, 2026) - Stock Titan
CalciMedica (NASDAQ: CALC) plans reverse split, 7.5M-share equity plan boost and warrant votes - Stock Titan
Price to earnings forward of CalciMedica, Inc. – NASDAQ:CALC - TradingView
Enterprise value to revenue forward of CalciMedica, Inc. – NASDAQ:CALC - TradingView
CalciMedica (CALC): CVI Investments and Heights Capital disclose 5.1% equity stake - Stock Titan
Enterprise value to EBITDA forward of CalciMedica, Inc. – NASDAQ:CALC - TradingView
CalciMedica (CALC) price target decreased by 24.39% to 10.54 - MSN
Form PRE 14A ATAI Beckley Inc For: 13 July By Investing.com - Investing.com Australia
CalciMedica (NASDAQ: CALC) plans reverse split and warrant votes - Stock Titan
CalciMedica Stock Short Interest Rises to 33.91% - Moomoo
CALC News | CALCIMEDICA INC (NASDAQ:CALC) - ChartMill
[Form 3] CalciMedica, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Calcimedica Inc (CALC) 財務データ
収益
当期純利益
現金流量
EPS
0.52%
0.07%
大文字化:
|
ボリューム (24 時間):